340B Health

Who We Are

340B Health represents public and private nonprofit hospitals and health systems that participate in the 340B drug discount program.

Learn more about us

340B Informed

Specialty Drug Claims Costs Expected to Rise Almost 20 Percent

October 27, 2016—Healthcare payers expect claims costs for specialty and biotech drugs to rise by almost 20 percent next year, a leading health benefits consulting firm says....
Read More

Investors Press Drug Companies About Unjustified Price Increases

October 25, 2016—Socially responsible investors want 17 leading U.S. and foreign drug companies to provide "more comprehensive disclosure about the rationale for price increases."...
Read More

The Exchange